https://www.selleckchem.com/pr....oducts/Gefitinib.htm
OBJECTIVES In 2012, the US Preventive Services Task Force decreased the recommended frequency of cervical cytology screening to once every 3 years and recommended against testing women younger than 21 years regardless of sexual history. We evaluated the impact of this in 21 to 29-year-old women at a tertiary care academic medical center in 2011 and 2017. METHODS We retrospectively analyzed Papanicolaou test results at two time points in 21- to 29-year-old women. RESULTS There was a decrease in the number of high-grade lesions in 21- t
Like
Comment
Share
